S. Gleysteen

Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa.

A. Klibanski, K. Miller, M. Misra, 2008, Bone.

Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study.

D. Schoenfeld, A. Klibanski, K. Miller, 2011, The Journal of clinical endocrinology and metabolism.

Differences in trabecular plate and rod structure in premenopausal women across the weight spectrum.

A. Klibanski, K. Miller, M. Misra, 2019, The Journal of clinical endocrinology and metabolism.

Determinants of skeletal loss and recovery in anorexia nervosa.

A. Klibanski, S. Grinspoon, K. Miller, 2006, The Journal of clinical endocrinology and metabolism.

Preservation of neuroendocrine control of reproductive function despite severe undernutrition.

A. Klibanski, S. Grinspoon, K. Miller, 2004, The Journal of clinical endocrinology and metabolism.

Effects of Risedronate and Low-Dose Transdermal Testosterone on Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo-Controlled Study

D. Schoenfeld, A. Klibanski, M. Misra, 2011 .

Determinants of skeletal loss and recovery in anorexia nervosa.

A. Klibanski, S. Grinspoon, M. Misra, 2006, The Journal of clinical endocrinology and metabolism.

Sequential Therapy With Recombinant Human IGF‐1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo‐Controlled Trial

D. Schoenfeld, Rajiv Gupta, M. Bredella, 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Comparison of hip geometry, strength, and estimated fracture risk in women with anorexia nervosa and overweight/obese women.

Kamryn T. Eddy, Tara M. Holmes, M. Goldstein, 2014, The Journal of clinical endocrinology and metabolism.